Esa Heinonen - Concepedia

Author

Esa Heinonen

Orion Corporation (Finland)

Also Known As

ESA HEINONEN, Esa H Heinonen, Esa H. Heinonen, Esa Heinonen, Niklas Ekman

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Orion Corporation (Finland)University of Turku Orion Corporation (United Kingdom)University of Eastern Finland

About

Esa Heinonen is an author at Orion Corporation (Finland) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	498
2	Social Sciences	5	5	213
3	Anesthesia	1	1	26
4	Applied Physiology	1	1	18
5	Kinesiology	1	1	18

Esa Heinonen

Publications

671

Citations

H-Index

Page 1

	Year	Citations
Evaluation of the effects of a specific α2-adrenoceptor antagonist, atipamezole, on α1- and α2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine Antti Haapalinna, Timo Viitamaa, Ewen MacDonald, Naunyn-Schmiedeberg s Archives of Pharmacology Molecular PharmacologyBehavioral NeuroscienceMedicineBehavioural PharmacologyBehavioral Pharmacology	1997	86
Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy Harri Hirvonen, Toivo T. Salmi, Esa Heinonen, Cancer	1989	62
Lack of Adverse Interactions Between Concomitantly Administered Selegiline and Citalopram Kari Laine, Markku Anttila, Esa Heinonen, Clinical Neuropharmacology Drug SafetyDrug InteractionsHypertensionPsychiatrySelegiline Alone	1997	52
Selegiline Treatment Facilitates Recovery After Stroke Juhani Sivenius, Taneli Sarasoja, Helena Aaltonen, Neurorehabilitation and neural repair	2001	46
Dexmedetomidine, Diazepam, and Propranolol in the Treatment of Ethanol Withdrawal Symptoms in the Rat Päivi Riihioja, Pia Jaatinen, Hanna Oksanen, Alcoholism Clinical and Experimental Research Substance AbuseEthanol Withdrawal SyndromeControl GroupPsychoactive DrugPsychiatry	1997	43
Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat Päivi Riihioja, Pia Jaatinen, Hanna M. Oksanen, Alcohol AddictionMedicineNeuropharmacologyAddiction MedicinePharmacotherapy	1997	40
Monoamine oxidase B inhibitor selegiline protects young and aged rat peripheral sympathetic neurons against 6-hydroxydopamine-induced neurotoxicity Tapani Salonen, Antti Haapalinna, Esa Heinonen, Acta Neuropathologica NeuropeptidesNeurophysiologyMedicine6-Hydroxydopamine-induced NeurotoxicityNeuropharmacology	1996	37
Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine Lennart Persson, Elinor Ben‐Menachem, Erland Bengtsson, Epilepsy Research Conventional Carbamazepine PreparationMedicinePsychotropic MedicationSide EffectsNeuropharmacology	1990	35
The ?2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats Antti Haapalinna, Tiina Leino, Esa Heinonen Naunyn-Schmiedeberg s Archives of Pharmacology Medicine2-Adrenoceptor AntagonistPharmacological AgentNeuropharmacologyPharmacotherapy	2003	34
Multiple-Dose Pharmacokinetics of Selegiline and Desmethylselegiline Suggest Saturable Tissue Binding Kari Laine, Markku Anttila, Risto Huupponen, Clinical Neuropharmacology Medicinal ChemistryPharmaceutical SciencePharmacological StudyPhysiologyPharmacology	2000	33

Page 1